Table 2.

Diagnostic and treatment process of patients diagnosed with pancreatic cancer in 2017–2019 and 2020

In grey the total number of patients included in each analysis per variable.

Missings 2017–2019 and 2020 in percentage (%): Interval first consultation-start treatment 1% and 0.5%, Multidisciplinary team discussion 2% and 1%, Interval first consultation-start treatment 1% and 1%, Reason no treatment 6% and 5%, Interval resection-start adjuvant therapy 4% and 3%, Type of adjuvant systemic therapy 1% and 1%, Type of palliative systemic therapy (no resection) 0.3% and 0.3%.